BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24398325)

  • 21. [Detection of translocation t(8;14)(q24;132) in pediatric Burkitt's lymphomas using "long distance" polymerase chain reaction: a new method for diagnosis of Burkitt's lymphomas].
    zur Stadt U; Reiter A; Welte K; Sykora KW
    Klin Padiatr; 1997; 209(4):165-71. PubMed ID: 9340426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic progression of post-transplant Burkitt-like lymphoma case with 11q-Gain/Loss and MYC amplification.
    Grygalewicz B; Woroniecka R; Rymkiewicz G; Rygier J; Malawska N; Blachnio K; Bystydzienski Z; Borysiuk A; Nowakowska B; Pienkowska-Grela B
    Cancer Genet; 2020 Jul; 245():1-5. PubMed ID: 32531723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon.
    Zani VJ; Asou N; Jadayel D; Heward JM; Shipley J; Nacheva E; Takasuki K; Catovsky D; Dyer MJ
    Blood; 1996 Apr; 87(8):3124-34. PubMed ID: 8605326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential IgM expression distinguishes two types of pediatric Burkitt lymphoma in mouse and human.
    Eason AB; Sin SH; Lin C; Damania B; Park S; Fedoriw Y; Bacchi CE; Dittmer DP
    Oncotarget; 2016 Sep; 7(39):63504-63513. PubMed ID: 27566574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker.
    Hurwitz SN; Lockhart B; Önder Ö; Wu R; Sethi S; Aypar U; Siebert R; Dogan A; Pillai V; Elenitoba-Johnson KSJ; Lim MS
    Mod Pathol; 2023 Jul; 36(7):100170. PubMed ID: 36997001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel genomic imbalances and chromosome translocations involving c-myc gene in Burkitt's lymphoma.
    Zimonjic DB; Keck-Waggoner C; Popescu NC
    Leukemia; 2001 Oct; 15(10):1582-8. PubMed ID: 11587216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-grade B-cell lymphoma with 11q aberrations: A single-center study.
    Yamada S; Oka Y; Muramatsu M; Hashimoto Y
    J Clin Exp Hematop; 2023; 63(2):121-131. PubMed ID: 37380468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement.
    Pienkowska-Grela B; Rymkiewicz G; Grygalewicz B; Woroniecka R; Krawczyk P; Czyz-Domanska K; Walewski J
    Med Oncol; 2011 Dec; 28(4):1589-95. PubMed ID: 20661666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicopathologic characteristics of Burkitt-like lymphoma with chromosome 11q aberration].
    Wei P; Zhang YL; Xie JL; Zheng YY; Liu W; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):176-179. PubMed ID: 29534356
    [No Abstract]   [Full Text] [Related]  

  • 30. LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.
    Colomo L; Vazquez I; Papaleo N; Espinet B; Ferrer A; Franco C; Comerma L; Hernandez S; Calvo X; Salar A; Climent F; Mate JL; Forcada P; Mozos A; Nonell L; Martinez A; Carrio A; Costa D; Dlouhy I; Salaverria I; Martin-Subero JI; Lopez-Guillermo A; Valera A; Campo E;
    Am J Surg Pathol; 2017 Jul; 41(7):877-886. PubMed ID: 28288039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
    Bouska A; Bi C; Lone W; Zhang W; Kedwaii A; Heavican T; Lachel CM; Yu J; Ferro R; Eldorghamy N; Greiner TC; Vose J; Weisenburger DD; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; Siebert R; Miles RR; Dave S; Reddy A; Delabie J; Staudt LM; Song JY; McKeithan TW; Fu K; Green M; Chan WC; Iqbal J
    Blood; 2017 Oct; 130(16):1819-1831. PubMed ID: 28801451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
    Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
    Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective analysis of minimal bone marrow infiltration in pediatric Burkitt's lymphomas by long-distance polymerase chain reaction for t(8;14)(q24;q32).
    Mussolin L; Basso K; Pillon M; D'Amore ES; Lombardi A; Luzzatto L; Zanesco L; Rosolen A
    Leukemia; 2003 Mar; 17(3):585-9. PubMed ID: 12646948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supernumerary isochromosome 1, idic(1)(p12), leading to tetrasomy 1q in Burkitt lymphoma.
    Roug AS; Wendtland P; Bendix K; Kjeldsen E
    Cytogenet Genome Res; 2014; 142(1):7-13. PubMed ID: 24217199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
    Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
    Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
    Kodet R; Mrhalová M; Stejskalová E; Kabícková E
    Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and pathological features of Burkitt lymphoma showing expression of BCL2--an analysis including gene expression in formalin-fixed paraffin-embedded tissue.
    Masqué-Soler N; Szczepanowski M; Kohler CW; Aukema SM; Nagel I; Richter J; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2015 Nov; 171(4):501-8. PubMed ID: 26218299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.
    Havelange V; Ameye G; Théate I; Callet-Bauchu E; Mugneret F; Michaux L; Dastugue N; Penther D; Barin C; Collonge-Rame MA; Baranger L; Terré C; Nadal N; Lippert E; Laï JL; Cabrol C; Tigaud I; Herens C; Hagemeijer A; Raphael M; Libouton JM; Poirel HA;
    Genes Chromosomes Cancer; 2013 Jan; 52(1):81-92. PubMed ID: 23012230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new dual translocation of chromosome 14 in a pediatric Burkitt lymphoma/leukemia patient: t(8;14) and t(14;15).
    Quatrin M; Pasti C; Romano S; Iarossi B; Giménez V; Schuttenberg V; Costa A; Slavutsky I
    Cancer Genet; 2021 Nov; 258-259():131-134. PubMed ID: 34757246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma.
    Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Niino D; Ohshima K
    Pathol Int; 2015 Sep; 65(9):486-9. PubMed ID: 26182827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.